What if we could change how drugs are developed?

The pharmaceutical industry uses a legacy point-to-point sub-optimized approach to drug discovery and development that is inefficient, expensive, and too often ends in failure.

Valo has pioneered a new approach to target discovery and drug development—one that is based on human-centric data and machine learning at every step.

About us

Valo is a mission-driven technology company that was created with the belief that the drug discovery and development process can and should be better—faster, less expensive, and with a higher probability of success.

Founded by Flagship Pioneering, Valo is using human-centric data and machine learning computation to transform the drug discovery and development process. As a digitally native company, Valo is the first to fully integrate human-centric data across the entire drug development lifecycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing the cost, time, and failure rate.

Valo's Opal Computational Platform™, a fully integrated, componentized, end-to-end drug development platform, offers a unique approach to therapeutic development that enables Valo to advance a robust pipeline of candidates across cardiovascular disease, oncology, and neurodegeneration.


Setting the pace for future discovery.

Meet our team of preeminent leaders in science, technology, pharmaceuticals, and public policy, united to change the world.